Heilongjiang ZBD Pharmaceutical Co., Ltd. (SHA:603567)

SHA:603567 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	946.17	1,454	1,001	1,551	1,539	2,554
Short-Term Investments	19.52	14.74	59.45	13.63	-	-
Trading Asset Securities	0.47	0.43	0.51	-	-	-
Cash & Short-Term Investments	966.16	1,469	1,061	1,565	1,539	2,554
Cash Growth	13.11%	38.43%	-32.17%	1.68%	-39.74%	13.26%
Accounts Receivable	3,365	2,525	3,041	3,369	2,654	2,165
Other Receivables	1,453	1,955	811.14	796.85	125.62	128.83
Receivables	4,819	4,480	3,852	4,166	2,779	2,294
Inventory	1,282	720.89	1,006	733.26	959.54	720.33
Prepaid Expenses	-	22.2	67.58	56.75	0.05	4.65
Other Current Assets	424.27	475.59	394.31	155.07	722.92	192.63
Total Current Assets	7,491	7,168	6,381	6,676	6,001	5,766
Property, Plant & Equipment	1,383	1,426	1,468	1,455	1,460	1,550
Long-Term Investments	1,289	1,266	1,223	1,236	859.65	243.96
Goodwill	14.82	14.82	17.22	18.5	18.5	16.1
Other Intangible Assets	806.95	784.03	764.29	209.36	205.05	237.27
Long-Term Deferred Tax Assets	328.91	302.6	242.28	159.23	149.9	115.12
Long-Term Deferred Charges	213.4	223.03	217.62	167.05	88.21	47.4
Other Long-Term Assets	1,175	1,282	1,364	1,585	1,452	1,043
Total Assets	12,703	12,466	11,678	11,506	10,234	9,019
Accounts Payable	234.52	332.99	806.25	797	581.33	249.66
Accrued Expenses	20.37	43.92	35.76	34.99	100.77	71.82
Short-Term Debt	1,366	876.19	1,302	600.76	500	1,326
Current Portion of Long-Term Debt	625.85	972.69	1,142	1,047	574	230
Current Portion of Leases	-	3.8	12.46	3.23	-	-
Current Income Taxes Payable	119.69	101.9	190.13	56.84	67.06	51.6
Current Unearned Revenue	136.46	36.46	54.97	12.98	41.04	22.73
Other Current Liabilities	285.2	387.2	323.34	259.28	387.97	450.8
Total Current Liabilities	2,788	2,755	3,867	2,812	2,252	2,402
Long-Term Debt	1,353	1,298	460	1,290	2,134	1,130
Long-Term Leases	0.14	0.14	9.96	3.53	-	-
Long-Term Unearned Revenue	155.49	169.34	181.88	197.24	197.08	157.66
Long-Term Deferred Tax Liabilities	25.63	26.02	5.91	1.37	-	-
Other Long-Term Liabilities	130.88	176.57	46.37	150.42	147.92	78.33
Total Liabilities	4,453	4,425	4,571	4,455	4,731	3,768
Common Stock	941.83	941.96	941.96	941.96	849.16	849.16
Additional Paid-In Capital	2,343	2,344	2,350	2,350	1,225	1,225
Retained Earnings	4,490	4,281	3,834	3,749	3,417	3,164
Treasury Stock	-20.88	-22.04	-29.99	-	-	-
Comprehensive Income & Other	4.65	3.93	3.2	2.75	3.62	3.45
Total Common Equity	7,759	7,548	7,099	7,043	5,494	5,242
Minority Interest	490.98	492.27	7.94	8.27	8.69	7.88
Shareholders' Equity	8,250	8,041	7,107	7,051	5,503	5,250
Total Liabilities & Equity	12,703	12,466	11,678	11,506	10,234	9,019
Total Debt	3,345	3,151	2,926	2,945	3,208	2,686
Net Cash (Debt)	-2,379	-1,682	-1,865	-1,380	-1,669	-132.13
Net Cash Per Share	-2.53	-1.79	-1.98	-1.60	-1.97	-0.16
Filing Date Shares Outstanding	939.4	939.4	939.4	941.96	849.16	849.16
Total Common Shares Outstanding	939.4	939.4	939.4	941.96	849.16	849.16
Working Capital	4,703	4,413	2,515	3,864	3,749	3,363
Book Value Per Share	8.26	8.04	7.56	7.48	6.47	6.17
Tangible Book Value	6,937	6,750	6,317	6,815	5,271	4,989
Tangible Book Value Per Share	7.38	7.18	6.72	7.23	6.21	5.88
Buildings	-	1,228	1,232	1,276	1,272	1,275
Machinery	-	1,191	1,139	1,118	1,176	1,084
Construction In Progress	-	284.29	260.83	137.33	66.14	133.43

Updated Oct 29, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.